journal article·2022-07-04Open access

Tracking Heme-Protein Interactions in Healthy and Pathological Human Serum in Native Conditions by Miniaturized FFF-Multidetection

Valentina Marassi, Stefano Giordani, Pierluigi Reschiglian, Barbara Roda, Andrea Zattoni

Applied Sciences· Volume 12· Issue 13

Abstract

The interaction of heme with blood serum proteins plays an important role in many physiological and pathological processes involving enzyme activity, gene expression and cell proliferation. The mechanisms underlying these interactions are; however, not yet fully understood. New analytical methods able to investigate protein-heme binding in native, biologically representative conditions are thus required. In this work, we present a method based on miniaturized, hollow-fiber flow field-flow fractionation with multiple spectrophotometric and light-scattering detection for size separation of high-abundance serum proteins and selective detection of heme-bound subpopulations. Heme is found to mainly interact with serum albumin, whereas a low amount also binds to other proteins such as IgM. The ability to bind heme in physiological conditions is also investigated for individual serum proteins. IgG is found unable to bind heme at clinically relevant concentrations. The proposed method allows separation, quantitation, and mass/size characterization of serum high-abundance proteins, providing information of heme-protein complex stability and preferred heme-clearing pathways. The same approach could be in perspective extended to the investigation of specific heme-antibody binding, and to further studies involving other molecules of pharmaceutical/clinical interest.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Field-Flow Fractionation Techniques · Heme Oxygenase-1 and Carbon Monoxide · Radiation Therapy and Dosimetry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry G. Ciamician, University of Bologna, 40126 Bologna, Italy

byFlow SRL, 40129 Bologna, Italy

References (62)

Show source-provided references
1. Free heme toxicity and its detoxification systems in human10.1016/j.toxlet.2005.03.004 ↗
2. COX-2, HO NO! Cyclooxygenase-2, heme oxygenase and nitric oxide synthase: Their role and interactions in inflammation. BIRAs Symposium, Saint Bartholomew’s Hospital, London, 26 April 199610.1007/s000110050187 ↗
3. Cell biology of heme10.1016/S0002-9629(15)40628-7 ↗
4. Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach110.1093/emboj/20.11.2835 ↗
5. Heme in pathophysiology: A matter of scavenging, metabolism and trafficking across cell membranes10.3389/fphar.2014.00061 ↗
6. Heme and the vasculature: An oxidative hazard that induces antioxidant defenses in the endothelium10.3109/10731199409117415 ↗
7. Pro-oxidant and cytotoxic effects of circulating heme10.1182/blood.V100.3.879 ↗
8. Heme scavenging and the other facets of hemopexin10.1089/ars.2009.2787 ↗
9. Mechanisms of cell protection by heme oxygenase-110.1146/annurev.pharmtox.010909.105600 ↗
10. Red cells, hemoglobin, heme, iron, and atherogenesis10.1161/ATVBAHA.110.206433 ↗
11. Cell-free hemoglobin and its scavenger proteins: New disease models leading the way to targeted therapies10.1101/cshperspect.a013433 ↗
12. Laboratory Approach to Hemolytic Anemia10.1007/s12098-019-03119-8 ↗
13. Hemoglobin and heme scavenging10.1080/15216540500380871 ↗
14. Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions10.1074/jbc.M702751200 ↗
15. Heme: Modulator of Plasma Systems in Hemolytic Diseases10.1016/j.molmed.2016.01.004 ↗
16. Redox-reactive autoantibodies: Detection and physiological relevance10.1016/j.autrev.2005.07.009 ↗
17. Autoantibodies unmasked by redox reactions10.1016/j.jaut.2005.03.005 ↗
18. Method for identification of heme-binding proteins and quantification of their interactions10.1016/j.ab.2020.113865 ↗
19. Interaction of clinical-stage antibodies with heme predicts their physiochemical and binding qualities10.1038/s42003-021-01931-7 ↗
20. Journet, L., and Cascales, E. (2017). Protein–Protein Interactions: Co-Immunoprecipitation. Bacterial Protein Secretion Systems: Methods and Protocols, Springer.10.1007/978-1-4939-7033-9 ↗
21. Chakraborty, A., Boel, N.M., and Edkins, A.L. (2020). HSP90 Interacts with the Fibronectin N-terminal Domains and Increases Matrix Formation. Cells, 9.10.3390/cells9020272 ↗
22. Pérez-Domínguez, S., Caballero-Mancebo, S., Marcuello, C., Martínez-Júlvez, M., Medina, M., and Lostao, A. (2022). Nanomechanical Study of Enzyme: Coenzyme Complexes: Bipartite Sites in Plastidic Ferredoxin-NADP+ Reductase for the Interaction with NADP+. Antioxidants, 11.10.3390/antiox11030537 ↗
23. Marcuello, C., de Miguel, R., and Lostao, A. (2022). Molecular Recognition of Proteins through Quantitative Force Maps at Single Molecule Level. Biomolecules, 12.10.3390/biom12040594 ↗
24. Fabian, R., Gaire, S., Tyson, C., Adhikari, R., Pegg, I., and Sarkar, A. (2021). A Horizontal Magnetic Tweezers for Studying Single DNA Molecules and DNA-Binding Proteins. Molecules, 26.10.3390/molecules26164781 ↗
25. Zhang, R., Wang, Y., and Yang, G. (2022). DNA–Lysozyme Nanoarchitectonics: Quantitative Investigation on Charge Inversion and Compaction. Polymers, 14.10.3390/polym14071377 ↗
26. Photoswitching FRET to monitor protein–protein interactions10.1073/pnas.1805333116 ↗
27. Qiao, Y., Luo, Y., Long, N., Xing, Y., and Tu, J. (2021). Single-Molecular Förster Resonance Energy Transfer Measurement on Structures and Interactions of Biomolecules. Micromachines, 12.10.3390/mi12050492 ↗
28. El Khamlichi, C., Reverchon-Assadi, F., Hervouet-Coste, N., Blot, L., Reiter, E., and Morisset-Lopez, S. (2019). Bioluminescence Resonance Energy Transfer as a Method to Study Protein-Protein Interactions: Application to G Protein Coupled Receptor Biology. Molecules, 24.10.3390/molecules24030537 ↗
29. Fujimoto, A., Lyu, Y., Kinjo, M., and Kitamura, A. (2021). Interaction between Spike Protein of SARS-CoV-2 and Human Virus Receptor ACE2 Using Two-Color Fluorescence Cross-Correlation Spectroscopy. Appl. Sci., 11.10.1101/2021.08.18.456769 ↗
30. Jakobowska, I., Becker, F., Minguzzi, S., Hansen, K., Henke, B., Epalle, N.H., Beitz, E., and Hannus, S. (2021). Fluorescence Cross-Correlation Spectroscopy Yields True Affinity and Binding Kinetics of Plasmodium Lactate Transport Inhibitors. Pharmaceuticals, 14.10.3390/ph14080757 ↗
31. Spectroscopic studies on human serum albumin and methemalbumin: Optical, steady-state, and picosecond time-resolved fluorescence studies, and kinetics of substrate oxidation by methemalbumin10.1007/s007750100294 ↗
32. Ibuprofen modulates allosterically NO dissociation from ferrous nitrosylated human serum heme-albumin by binding to three sites10.1016/j.bbrc.2009.06.117 ↗
33. Use of cysteine as a spectroscopic probe for of heme-scavenging capacity of serum proteins and whole human serum10.1016/j.jpba.2019.05.013 ↗
34. Proteins and antibodies in serum, plasma, and whole blood-size characterization using asymmetrical flow field-flow fractionation (AF4)10.1007/s00216-018-1127-2 ↗
35. An Analytical Method for Size and Shape Characterization of Blood Lipoproteins10.1373/clinchem.2007.091942 ↗
36. Hollow-fiber flow field-flow fractionation of whole blood serum10.1016/j.chroma.2008.01.022 ↗
37. Field flow fractionation techniques to explore the “nano-world”10.1007/s00216-017-0180-6 ↗
38. Hollow fiber flow field-flow fractionation and size-exclusion chromatography with MALS detection: A complementary approach in biopharmaceutical industry10.1016/j.chroma.2014.10.072 ↗
39. Hollow-fiber flow field-flow fractionation and multi-angle light scattering investigation of the size, shape and metal-release of silver nanoparticles in aqueous medium for nano-risk assessment10.1016/j.jpba.2014.11.031 ↗
40. A new approach for the separation, characterization and testing of potential prionoid protein aggregates through hollow-fiber flow field-flow fractionation and multi-angle light scattering10.1016/j.aca.2019.08.003 ↗
41. FFF-based high-throughput sequence shortlisting to support the development of aptamer-based analytical strategies10.1007/s00216-022-03971-2 ↗
42. Widening the Therapeutic Perspectives of Clofazimine by Its Loading in Sulfobutylether β-Cyclodextrin Nanocarriers: Nanomolar IC(50) Values against MDR S. epidermidis10.1021/acs.molpharmaceut.8b00321 ↗
43. Field-flow fractionation for molecular-interaction studies of labile and complex systems: A critical review10.1016/j.aca.2021.339396 ↗
44. Flow field-flow fractionation with multiangle light scattering detection for the analysis and characterization of functional nanoparticles10.1007/s00216-010-4197-3 ↗
45. Silver nanoparticles as a medical device in healthcare settings: A five-step approach for candidate screening of coating agents10.1098/rsos.171113 ↗
46. Marassi, V., Casolari, S., Panzavolta, S., Bonvicini, F., Gentilomi, G.A., Giordani, S., Zattoni, A., Reschiglian, P., and Roda, B. (2022). Synthesis Monitoring, Characterization and Cleanup of Ag-Polydopamine Nanoparticles Used as Antibacterial Agents with Field-Flow Fractionation. Antibiotics, 11.10.3390/antibiotics11030358 ↗
47. Flow field-flow fractionation and multi-angle light scattering as a powerful tool for the characterization and stability evaluation of drug-loaded metal-organic framework nanoparticles10.1007/s00216-018-1176-6 ↗
48. Comprehensive characterization of gold nanoparticles and their protein conjugates used as a label by hollow fiber flow field flow fractionation with photodiode array and fluorescence detectors and multiangle light scattering10.1016/j.chroma.2020.461739 ↗
49. An ultracentrifugation–hollow-fiber flow field-flow fractionation orthogonal approach for the purification and mapping of extracellular vesicle subtypes10.1016/j.chroma.2020.461861 ↗
50. Perspectives on protein biopolymers: Miniaturized flow field-flow fractionation-assisted characterization of a single-cysteine mutated phaseolin expressed in transplastomic tobacco plants10.1016/j.chroma.2020.461806 ↗
51. Characterization of red wine native colloids by asymmetrical flow field-flow fractionation with online multidetection10.1016/j.foodhyd.2020.106204 ↗
52. Hollow-fiber flow field-flow fractionation and multi-angle light scattering as a new analytical solution for quality control in pharmaceutical nanotechnology10.1016/j.microc.2016.12.015 ↗
53. Hollow-fiber flow field-flow fractionation with multi-angle laser scattering detection for aggregation studies of therapeutic proteins Field-Flow Fractionation10.1007/s00216-013-7462-4 ↗
54. Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: A retrospective study from a hematology tertiary care center10.3324/haematol.2019.219725 ↗
55. Practical Handbook of Biochemistry and Molecular Biology: Edited by G D Fasman. pp 601. CRC Press: Boca Raton, Florida, USA. 1989. $00 ISBN 0-8493-3705-410.1016/0307-4412(91)90020-9 ↗
56. Asymmetric flow field flow fractionation for the investigation of caseins cross-linked by microbial transglutaminase10.1016/j.foodhyd.2019.01.043 ↗
57. Karnaukhova, E., Owczarek, C., Schmidt, P., Schaer, D.J., and Buehler, P.W. (2021). Human Plasma and Recombinant Hemopexins: Heme Binding Revisited. Int. J. Mol. Sci., 22.10.3390/ijms22031199 ↗
58. Rivas-Urbina, A., Rull, A., Aldana-Ramos, J., Santos, D., Puig, N., Farre-Cabrerizo, N., Benitez, S., Perez, A., de Gonzalo-Calvo, D., and Escola-Gil, J.C. (2020). Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice. Biomolecules, 10.10.3390/biom10060829 ↗
59. Oxidative Modification of LDL by Various Physicochemical Techniques: Its Probable Role in Diabetes Coupled with CVDs10.1155/2018/7390612 ↗
60. Induced antigen-binding polyreactivity in human serum IgA10.1016/j.imbio.2022.152213 ↗
61. Hart, F., Danielczyk, A., and Goletz, S. (2017). Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy. Bioengineering, 4.10.3390/bioengineering4020042 ↗
62. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease10.3389/fimmu.2020.561917 ↗